フルサービスCDMOの世界市場に関する洞察、2030年までの予測

当レポートは、フルサービスCDMO (Full-Service CDMO) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場分析：タイプ別
  • 世界のフルサービスCDMOの市場規模成長率：タイプ別: 2019 VS 2023 VS 2030
  • API CDMO
  • FDF CDMO
  • Packaging CDMO
  • Clinical CDMO
• 市場：用途別
  • 世界のフルサービスCDMOの市場シェア：用途別: 2019 VS 2023 VS 2030
  • Pharmaceutical Company
  • Biotechnology Company
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界のフルサービスCDMOの市場展望 (2019-2030)
• 世界のフルサービスCDMOの市場成長トレンド：地域別
  • 世界のフルサービスCDMO 市場規模：地域別: 2019 VS 2023 VS 2030
  • フルサービスCDMOの市場規模実績：地域別 (2019-2024)
  • フルサービスCDMOの市場規模予測：地域別 (2025-2030)
• フルサービスCDMO 市場動向
  • フルサービスCDMO 業界動向
  • フルサービスCDMO 市場の促進要因
  • フルサービスCDMO 市場の課題
  • フルサービスCDMO 市場の抑制要因

第3章 競合情勢：主要企業別

• 世界規模の売上高 フルサービスCDMO ：競合別
  • 世界のフルサービスCDMOの収益：企業別 (2019-2024)
  • 世界のフルサービスCDMOの収益シェア：企業別 (2019-2024)
• 世界のフルサービスCDMOの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要企業 フルサービスCDMO, 売上高ランキング, 2022 VS 2023 VS 2024
• 世界のフルサービスCDMO 市場集中度
  • 世界のフルサービスCDMO 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： フルサービスCDMOの収益 2023
• 世界の主要企業 フルサービスCDMO 本社 および提供地域
• 世界の主要企業 フルサービスCDMO, 製品およびアプリケーション
• 世界の主要企業 フルサービスCDMO, 業界参入時期
• M&A, 拡張計画

第4章 フルサービスCDMO 内訳データ：タイプ別

• 世界のフルサービスCDMOの市場規模実績：タイプ別 (2019-2024)
• 世界のフルサービスCDMOの市場規模予測：タイプ別 (2025-2030)

第5章 フルサービスCDMO 内訳データ：用途別

• 世界のフルサービスCDMOの市場規模実績：用途別 (2019-2024)
• 世界のフルサービスCDMOの市場規模予測：用途別 (2025-2030)

第6章 北米

• 北米のフルサービスCDMO 市場規模 (2019-2030)
• 北米のフルサービスCDMO 市場規模：タイプ別
  • 北米のフルサービスCDMO 市場規模：タイプ別 (2019-2024)
  • 北米のフルサービスCDMO 市場規模：タイプ別 (2025-2030)
  • 北米のフルサービスCDMOの市場シェア：タイプ別 (2019-2030)
• 北米のフルサービスCDMO 市場規模：用途別
  • 北米のフルサービスCDMO 市場規模：用途別 (2019-2024)
  • 北米のフルサービスCDMO 市場規模：用途別 (2025-2030)
  • 北米のフルサービスCDMOの市場シェア：用途別 (2019-2030)
• 北米のフルサービスCDMO 市場規模：国別
  • 北米のフルサービスCDMO 市場規模：国別: 2019 VS 2023 VS 2030
  • 北米のフルサービスCDMO 市場規模：国別 (2019-2024)
  • 北米のフルサービスCDMO 市場 シェア 国別 (2025-2030)
  • 米国
  • カナダ

第7章 欧州

• 欧州のフルサービスCDMO 市場規模 (2019-2030)
• 欧州のフルサービスCDMO 市場規模：タイプ別
  • 欧州のフルサービスCDMO 市場規模：タイプ別 (2019-2024)
  • 欧州のフルサービスCDMO 市場規模：タイプ別 (2025-2030)
  • 欧州のフルサービスCDMOの市場シェア：タイプ別 (2019-2030)
• 欧州のフルサービスCDMO 市場規模：用途別
  • 欧州のフルサービスCDMO 市場規模：用途別 (2019-2024)
  • 欧州のフルサービスCDMO 市場規模：用途別 (2025-2030)
  • 欧州のフルサービスCDMOの市場シェア：用途別 (2019-2030)
• 欧州のフルサービスCDMO 市場規模：国別
  • 欧州のフルサービスCDMO 市場規模：国別: 2019 VS 2023 VS 2030
  • 欧州のフルサービスCDMO 市場規模：国別 (2019-2024)
  • 欧州のフルサービスCDMO 市場規模：国別 (2025-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧

第8章 中国

• 中国のフルサービスCDMO 市場規模 (2019-2030)
• 中国のフルサービスCDMO 市場規模：タイプ別
  • 中国のフルサービスCDMO 市場規模：タイプ別 (2019-2024)
  • 中国のフルサービスCDMO 市場規模：タイプ別 (2025-2030)
  • 中国のフルサービスCDMOの市場シェア：タイプ別 (2019-2030)
• 中国のフルサービスCDMO 市場規模：用途別
  • 中国のフルサービスCDMO 市場規模：用途別 (2019-2024)
  • 中国のフルサービスCDMO 市場規模：用途別 (2025-2030)
  • 中国のフルサービスCDMOの市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 フルサービスCDMO 市場規模 (2019-2030)
• アジア地域 フルサービスCDMO 市場規模：タイプ別
  • アジア地域 フルサービスCDMO 市場規模：タイプ別 (2019-2024)
  • アジア地域 フルサービスCDMO 市場規模：タイプ別 (2025-2030)
  • アジア地域 フルサービスCDMOの市場シェア：タイプ別 (2019-2030)
• アジア地域 フルサービスCDMO 市場規模：用途別
  • アジア地域 フルサービスCDMO 市場規模：用途別 (2019-2024)
  • アジア地域 フルサービスCDMO 市場規模：用途別 (2025-2030)
  • アジア地域 フルサービスCDMOの市場シェア：用途別 (2019-2030)
• アジア地域 フルサービスCDMO 市場規模：地域別
  • アジア地域 フルサービスCDMO 市場規模：地域別: 2019 VS 2023 VS 2030
  • アジア地域 フルサービスCDMO 市場規模：地域別 (2019-2024)
  • アジア地域 フルサービスCDMO 市場規模：地域別 (2025-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中近東・アフリカ・中南米

• 中近東・アフリカ・中南米 フルサービスCDMO 市場規模 (2019-2030)
• 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：タイプ別
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：タイプ別 (2019-2024)
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：タイプ別 (2025-2030)
  • 中近東・アフリカ・中南米 フルサービスCDMOの市場シェア：タイプ別 (2019-2030)
• 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：用途別
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：用途別 (2019-2024)
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：用途別 (2025-2030)
  • 中近東・アフリカ・中南米 フルサービスCDMOの市場シェア：用途別 (2019-2030)
• 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：国別
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：国別: 2019 VS 2023 VS 2030
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：国別 (2019-2024)
  • 中近東・アフリカ・中南米 フルサービスCDMO 市場規模：国別 (2025-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • サウジアラビア
  • イスラエル
  • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

• Lonza
• Catalent
• Thermo Fisher Scientific
• Samsung Biologics
• Fareva
• WuXi AppTech
• WuXi Biologics
• Siegfried
• FUJIFILM Diosynth Biotechnologies
• Asymchem
• Pfizer CentreOne
• Delpharm
• Recipharm
• AGC Pharma Chemicals
• Boehringer Ingelheim
• Vetter
• Curia
• Aenova
• Porton
• Piramal
• Strides Pharma
• NextPharma
• Famar
• Jubilant
• Alcami
• Euroapi
• Eurofins
• Avid Bioservices
• BioVectra
• CPL

第12章 アナリストによる分析/結論

第13章 付録

List of Tables

Table 1. Global Full-Service CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of API CDMO

Table 3. Key Players of FDF CDMO

Table 4. Key Players of Packaging CDMO

Table 5. Key Players of Clinical CDMO

Table 6. Global Full-Service CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Full-Service CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Full-Service CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Full-Service CDMO Market Share by Region (2019-2024)

Table 10. Global Full-Service CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Full-Service CDMO Market Share by Region (2025-2030)

Table 12. Full-Service CDMO Market Trends

Table 13. Full-Service CDMO Market Drivers

Table 14. Full-Service CDMO Market Challenges

Table 15. Full-Service CDMO Market Restraints

Table 16. Global Full-Service CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Full-Service CDMO Market Share by Players (2019-2024)

Table 18. Global Top Full-Service CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Full-Service CDMO as of 2023)

Table 19. Global Full-Service CDMO Industry Ranking 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Full-Service CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Full-Service CDMO, Headquarters and Area Served

Table 22. Global Key Players of Full-Service CDMO, Product and Application

Table 23. Global Key Players of Full-Service CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Full-Service CDMO Revenue Market Share by Type (2019-2024)

Table 27. Global Full-Service CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Full-Service CDMO Revenue Market Share by Type (2025-2030)

Table 29. Global Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Full-Service CDMO Revenue Market Share by Application (2019-2024)

Table 31. Global Full-Service CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Full-Service CDMO Revenue Market Share by Application (2025-2030)

Table 33. North America Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Full-Service CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Full-Service CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Full-Service CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Full-Service CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Full-Service CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Full-Service CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Full-Service CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Full-Service CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Full-Service CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Full-Service CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Full-Service CDMO Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Full-Service CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Full-Service CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Full-Service CDMO Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 65. Lonza Company Details

Table 66. Lonza Business Overview

Table 67. Lonza Full-Service CDMO Product

Table 68. Lonza Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 69. Lonza Recent Development

Table 70. Catalent Company Details

Table 71. Catalent Business Overview

Table 72. Catalent Full-Service CDMO Product

Table 73. Catalent Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 74. Catalent Recent Development

Table 75. Thermo Fisher Scientific Company Details

Table 76. Thermo Fisher Scientific Business Overview

Table 77. Thermo Fisher Scientific Full-Service CDMO Product

Table 78. Thermo Fisher Scientific Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 79. Thermo Fisher Scientific Recent Development

Table 80. Samsung Biologics Company Details

Table 81. Samsung Biologics Business Overview

Table 82. Samsung Biologics Full-Service CDMO Product

Table 83. Samsung Biologics Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 84. Samsung Biologics Recent Development

Table 85. Fareva Company Details

Table 86. Fareva Business Overview

Table 87. Fareva Full-Service CDMO Product

Table 88. Fareva Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 89. Fareva Recent Development

Table 90. WuXi AppTech Company Details

Table 91. WuXi AppTech Business Overview

Table 92. WuXi AppTech Full-Service CDMO Product

Table 93. WuXi AppTech Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 94. WuXi AppTech Recent Development

Table 95. WuXi Biologics Company Details

Table 96. WuXi Biologics Business Overview

Table 97. WuXi Biologics Full-Service CDMO Product

Table 98. WuXi Biologics Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 99. WuXi Biologics Recent Development

Table 100. Siegfried Company Details

Table 101. Siegfried Business Overview

Table 102. Siegfried Full-Service CDMO Product

Table 103. Siegfried Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 104. Siegfried Recent Development

Table 105. FUJIFILM Diosynth Biotechnologies Company Details

Table 106. FUJIFILM Diosynth Biotechnologies Business Overview

Table 107. FUJIFILM Diosynth Biotechnologies Full-Service CDMO Product

Table 108. FUJIFILM Diosynth Biotechnologies Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 109. FUJIFILM Diosynth Biotechnologies Recent Development

Table 110. Asymchem Company Details

Table 111. Asymchem Business Overview

Table 112. Asymchem Full-Service CDMO Product

Table 113. Asymchem Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 114. Asymchem Recent Development

Table 115. Pfizer CentreOne Company Details

Table 116. Pfizer CentreOne Business Overview

Table 117. Pfizer CentreOne Full-Service CDMO Product

Table 118. Pfizer CentreOne Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 119. Pfizer CentreOne Recent Development

Table 120. Delpharm Company Details

Table 121. Delpharm Business Overview

Table 122. Delpharm Full-Service CDMO Product

Table 123. Delpharm Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 124. Delpharm Recent Development

Table 125. Recipharm Company Details

Table 126. Recipharm Business Overview

Table 127. Recipharm Full-Service CDMO Product

Table 128. Recipharm Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 129. Recipharm Recent Development

Table 130. AGC Pharma Chemicals Company Details

Table 131. AGC Pharma Chemicals Business Overview

Table 132. AGC Pharma Chemicals Full-Service CDMO Product

Table 133. AGC Pharma Chemicals Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 134. AGC Pharma Chemicals Recent Development

Table 135. Boehringer Ingelheim Company Details

Table 136. Boehringer Ingelheim Business Overview

Table 137. Boehringer Ingelheim Full-Service CDMO Product

Table 138. Boehringer Ingelheim Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 139. Boehringer Ingelheim Recent Development

Table 140. Vetter Company Details

Table 141. Vetter Business Overview

Table 142. Vetter Full-Service CDMO Product

Table 143. Vetter Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 144. Vetter Recent Development

Table 145. Curia Company Details

Table 146. Curia Business Overview

Table 147. Curia Full-Service CDMO Product

Table 148. Curia Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 149. Curia Recent Development

Table 150. Aenova Company Details

Table 151. Aenova Business Overview

Table 152. Aenova Full-Service CDMO Product

Table 153. Aenova Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 154. Aenova Recent Development

Table 155. Porton Company Details

Table 156. Porton Business Overview

Table 157. Porton Full-Service CDMO Product

Table 158. Porton Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 159. Porton Recent Development

Table 160. Piramal Company Details

Table 161. Piramal Business Overview

Table 162. Piramal Full-Service CDMO Product

Table 163. Piramal Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 164. Piramal Recent Development

Table 165. Strides Pharma Company Details

Table 166. Strides Pharma Business Overview

Table 167. Strides Pharma Full-Service CDMO Product

Table 168. Strides Pharma Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 169. Strides Pharma Recent Development

Table 170. NextPharma Company Details

Table 171. NextPharma Business Overview

Table 172. NextPharma Full-Service CDMO Product

Table 173. NextPharma Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 174. NextPharma Recent Development

Table 175. Famar Company Details

Table 176. Famar Business Overview

Table 177. Famar Full-Service CDMO Product

Table 178. Famar Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 179. Famar Recent Development

Table 180. Jubilant Company Details

Table 181. Jubilant Business Overview

Table 182. Jubilant Full-Service CDMO Product

Table 183. Jubilant Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 184. Jubilant Recent Development

Table 185. Alcami Company Details

Table 186. Alcami Business Overview

Table 187. Alcami Full-Service CDMO Product

Table 188. Alcami Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 189. Alcami Recent Development

Table 190. Euroapi Company Details

Table 191. Euroapi Business Overview

Table 192. Euroapi Full-Service CDMO Product

Table 193. Euroapi Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 194. Euroapi Recent Development

Table 195. Eurofins Company Details

Table 196. Eurofins Business Overview

Table 197. Eurofins Full-Service CDMO Product

Table 198. Eurofins Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 199. Eurofins Recent Development

Table 200. Avid Bioservices Company Details

Table 201. Avid Bioservices Business Overview

Table 202. Avid Bioservices Full-Service CDMO Product

Table 203. Avid Bioservices Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 204. Avid Bioservices Recent Development

Table 205. BioVectra Company Details

Table 206. BioVectra Business Overview

Table 207. BioVectra Full-Service CDMO Product

Table 208. BioVectra Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 209. BioVectra Recent Development

Table 210. CPL Company Details

Table 211. CPL Business Overview

Table 212. CPL Full-Service CDMO Product

Table 213. CPL Revenue in Full-Service CDMO Business (2019-2024) & (US$ Million)

Table 214. CPL Recent Development

Table 215. Research Programs/Design for This Report

Table 216. Key Data Information from Secondary Sources

Table 217. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Full-Service CDMO Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Full-Service CDMO Market Share by Type: 2023 VS 2030

Figure 3. API CDMO Features

Figure 4. FDF CDMO Features

Figure 5. Packaging CDMO Features

Figure 6. Clinical CDMO Features

Figure 7. Global Full-Service CDMO Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Full-Service CDMO Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical Company Case Studies

Figure 10. Biotechnology Company Case Studies

Figure 11. Full-Service CDMO Report Years Considered

Figure 12. Global Full-Service CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Full-Service CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Full-Service CDMO Market Share by Region: 2023 VS 2030

Figure 15. Global Full-Service CDMO Market Share by Players in 2023

Figure 16. Global Top Full-Service CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Full-Service CDMO as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Full-Service CDMO Revenue in 2023

Figure 18. North America Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Full-Service CDMO Market Share by Type (2019-2030)

Figure 20. North America Full-Service CDMO Market Share by Application (2019-2030)

Figure 21. North America Full-Service CDMO Market Share by Country (2019-2030)

Figure 22. United States Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Full-Service CDMO Market Share by Type (2019-2030)

Figure 26. Europe Full-Service CDMO Market Share by Application (2019-2030)

Figure 27. Europe Full-Service CDMO Market Share by Country (2019-2030)

Figure 28. Germany Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Full-Service CDMO Market Share by Type (2019-2030)

Figure 36. China Full-Service CDMO Market Share by Application (2019-2030)

Figure 37. Asia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia Full-Service CDMO Market Share by Type (2019-2030)

Figure 39. Asia Full-Service CDMO Market Share by Application (2019-2030)

Figure 40. Asia Full-Service CDMO Market Share by Region (2019-2030)

Figure 41. Japan Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Full-Service CDMO Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Full-Service CDMO Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Full-Service CDMO Market Share by Country (2019-2030)

Figure 51. Brazil Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Full-Service CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Lonza Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 58. Catalent Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 60. Samsung Biologics Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 61. Fareva Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 62. WuXi AppTech Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 63. WuXi Biologics Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 64. Siegfried Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 65. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 66. Asymchem Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 67. Pfizer CentreOne Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 68. Delpharm Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 69. Recipharm Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 70. AGC Pharma Chemicals Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 71. Boehringer Ingelheim Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 72. Vetter Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 73. Curia Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 74. Aenova Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 75. Porton Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 76. Piramal Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 77. Strides Pharma Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 78. NextPharma Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 79. Famar Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 80. Jubilant Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 81. Alcami Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 82. Euroapi Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 83. Eurofins Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 84. Avid Bioservices Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 85. BioVectra Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 86. CPL Revenue Growth Rate in Full-Service CDMO Business (2019-2024)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

This research report focuses on the Full-Service CDMO Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Full-Service CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 API CDMO
  • 1.2.3 FDF CDMO
  • 1.2.4 Packaging CDMO
  • 1.2.5 Clinical CDMO
• 1.3 Market by Application
  • 1.3.1 Global Full-Service CDMO Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Pharmaceutical Company
  • 1.3.3 Biotechnology Company
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Full-Service CDMO Market Perspective (2019-2030)
• 2.2 Global Full-Service CDMO Growth Trends by Region
  • 2.2.1 Global Full-Service CDMO Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Full-Service CDMO Historic Market Size by Region (2019-2024)
  • 2.2.3 Full-Service CDMO Forecasted Market Size by Region (2025-2030)
• 2.3 Full-Service CDMO Market Dynamics
  • 2.3.1 Full-Service CDMO Industry Trends
  • 2.3.2 Full-Service CDMO Market Drivers
  • 2.3.3 Full-Service CDMO Market Challenges
  • 2.3.4 Full-Service CDMO Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Full-Service CDMO by Players
  • 3.1.1 Global Full-Service CDMO Revenue by Players (2019-2024)
  • 3.1.2 Global Full-Service CDMO Revenue Market Share by Players (2019-2024)
• 3.2 Global Full-Service CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Full-Service CDMO, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Full-Service CDMO Market Concentration Ratio
  • 3.4.1 Global Full-Service CDMO Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Full-Service CDMO Revenue in 2023
• 3.5 Global Key Players of Full-Service CDMO Head office and Area Served
• 3.6 Global Key Players of Full-Service CDMO, Product and Application
• 3.7 Global Key Players of Full-Service CDMO, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Full-Service CDMO Breakdown Data by Type

• 4.1 Global Full-Service CDMO Historic Market Size by Type (2019-2024)
• 4.2 Global Full-Service CDMO Forecasted Market Size by Type (2025-2030)

5 Full-Service CDMO Breakdown Data by Application

• 5.1 Global Full-Service CDMO Historic Market Size by Application (2019-2024)
• 5.2 Global Full-Service CDMO Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Full-Service CDMO Market Size (2019-2030)
• 6.2 North America Full-Service CDMO Market Size by Type
  • 6.2.1 North America Full-Service CDMO Market Size by Type (2019-2024)
  • 6.2.2 North America Full-Service CDMO Market Size by Type (2025-2030)
  • 6.2.3 North America Full-Service CDMO Market Share by Type (2019-2030)
• 6.3 North America Full-Service CDMO Market Size by Application
  • 6.3.1 North America Full-Service CDMO Market Size by Application (2019-2024)
  • 6.3.2 North America Full-Service CDMO Market Size by Application (2025-2030)
  • 6.3.3 North America Full-Service CDMO Market Share by Application (2019-2030)
• 6.4 North America Full-Service CDMO Market Size by Country
  • 6.4.1 North America Full-Service CDMO Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Full-Service CDMO Market Size by Country (2019-2024)
  • 6.4.3 North America Full-Service CDMO Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Full-Service CDMO Market Size (2019-2030)
• 7.2 Europe Full-Service CDMO Market Size by Type
  • 7.2.1 Europe Full-Service CDMO Market Size by Type (2019-2024)
  • 7.2.2 Europe Full-Service CDMO Market Size by Type (2025-2030)
  • 7.2.3 Europe Full-Service CDMO Market Share by Type (2019-2030)
• 7.3 Europe Full-Service CDMO Market Size by Application
  • 7.3.1 Europe Full-Service CDMO Market Size by Application (2019-2024)
  • 7.3.2 Europe Full-Service CDMO Market Size by Application (2025-2030)
  • 7.3.3 Europe Full-Service CDMO Market Share by Application (2019-2030)
• 7.4 Europe Full-Service CDMO Market Size by Country
  • 7.4.1 Europe Full-Service CDMO Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Full-Service CDMO Market Size by Country (2019-2024)
  • 7.4.3 Europe Full-Service CDMO Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Full-Service CDMO Market Size (2019-2030)
• 8.2 China Full-Service CDMO Market Size by Type
  • 8.2.1 China Full-Service CDMO Market Size by Type (2019-2024)
  • 8.2.2 China Full-Service CDMO Market Size by Type (2025-2030)
  • 8.2.3 China Full-Service CDMO Market Share by Type (2019-2030)
• 8.3 China Full-Service CDMO Market Size by Application
  • 8.3.1 China Full-Service CDMO Market Size by Application (2019-2024)
  • 8.3.2 China Full-Service CDMO Market Size by Application (2025-2030)
  • 8.3.3 China Full-Service CDMO Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Full-Service CDMO Market Size (2019-2030)
• 9.2 Asia Full-Service CDMO Market Size by Type
  • 9.2.1 Asia Full-Service CDMO Market Size by Type (2019-2024)
  • 9.2.2 Asia Full-Service CDMO Market Size by Type (2025-2030)
  • 9.2.3 Asia Full-Service CDMO Market Share by Type (2019-2030)
• 9.3 Asia Full-Service CDMO Market Size by Application
  • 9.3.1 Asia Full-Service CDMO Market Size by Application (2019-2024)
  • 9.3.2 Asia Full-Service CDMO Market Size by Application (2025-2030)
  • 9.3.3 Asia Full-Service CDMO Market Share by Application (2019-2030)
• 9.4 Asia Full-Service CDMO Market Size by Region
  • 9.4.1 Asia Full-Service CDMO Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Full-Service CDMO Market Size by Region (2019-2024)
  • 9.4.3 Asia Full-Service CDMO Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Full-Service CDMO Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Full-Service CDMO Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Full-Service CDMO Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Full-Service CDMO Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Lonza
  • 11.1.1 Lonza Company Details
  • 11.1.2 Lonza Business Overview
  • 11.1.3 Lonza Full-Service CDMO Introduction
  • 11.1.4 Lonza Revenue in Full-Service CDMO Business (2019-2024)
  • 11.1.5 Lonza Recent Development
• 11.2 Catalent
  • 11.2.1 Catalent Company Details
  • 11.2.2 Catalent Business Overview
  • 11.2.3 Catalent Full-Service CDMO Introduction
  • 11.2.4 Catalent Revenue in Full-Service CDMO Business (2019-2024)
  • 11.2.5 Catalent Recent Development
• 11.3 Thermo Fisher Scientific
  • 11.3.1 Thermo Fisher Scientific Company Details
  • 11.3.2 Thermo Fisher Scientific Business Overview
  • 11.3.3 Thermo Fisher Scientific Full-Service CDMO Introduction
  • 11.3.4 Thermo Fisher Scientific Revenue in Full-Service CDMO Business (2019-2024)
  • 11.3.5 Thermo Fisher Scientific Recent Development
• 11.4 Samsung Biologics
  • 11.4.1 Samsung Biologics Company Details
  • 11.4.2 Samsung Biologics Business Overview
  • 11.4.3 Samsung Biologics Full-Service CDMO Introduction
  • 11.4.4 Samsung Biologics Revenue in Full-Service CDMO Business (2019-2024)
  • 11.4.5 Samsung Biologics Recent Development
• 11.5 Fareva
  • 11.5.1 Fareva Company Details
  • 11.5.2 Fareva Business Overview
  • 11.5.3 Fareva Full-Service CDMO Introduction
  • 11.5.4 Fareva Revenue in Full-Service CDMO Business (2019-2024)
  • 11.5.5 Fareva Recent Development
• 11.6 WuXi AppTech
  • 11.6.1 WuXi AppTech Company Details
  • 11.6.2 WuXi AppTech Business Overview
  • 11.6.3 WuXi AppTech Full-Service CDMO Introduction
  • 11.6.4 WuXi AppTech Revenue in Full-Service CDMO Business (2019-2024)
  • 11.6.5 WuXi AppTech Recent Development
• 11.7 WuXi Biologics
  • 11.7.1 WuXi Biologics Company Details
  • 11.7.2 WuXi Biologics Business Overview
  • 11.7.3 WuXi Biologics Full-Service CDMO Introduction
  • 11.7.4 WuXi Biologics Revenue in Full-Service CDMO Business (2019-2024)
  • 11.7.5 WuXi Biologics Recent Development
• 11.8 Siegfried
  • 11.8.1 Siegfried Company Details
  • 11.8.2 Siegfried Business Overview
  • 11.8.3 Siegfried Full-Service CDMO Introduction
  • 11.8.4 Siegfried Revenue in Full-Service CDMO Business (2019-2024)
  • 11.8.5 Siegfried Recent Development
• 11.9 FUJIFILM Diosynth Biotechnologies
  • 11.9.1 FUJIFILM Diosynth Biotechnologies Company Details
  • 11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
  • 11.9.3 FUJIFILM Diosynth Biotechnologies Full-Service CDMO Introduction
  • 11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Full-Service CDMO Business (2019-2024)
  • 11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
• 11.10 Asymchem
  • 11.10.1 Asymchem Company Details
  • 11.10.2 Asymchem Business Overview
  • 11.10.3 Asymchem Full-Service CDMO Introduction
  • 11.10.4 Asymchem Revenue in Full-Service CDMO Business (2019-2024)
  • 11.10.5 Asymchem Recent Development
• 11.11 Pfizer CentreOne
  • 11.11.1 Pfizer CentreOne Company Details
  • 11.11.2 Pfizer CentreOne Business Overview
  • 11.11.3 Pfizer CentreOne Full-Service CDMO Introduction
  • 11.11.4 Pfizer CentreOne Revenue in Full-Service CDMO Business (2019-2024)
  • 11.11.5 Pfizer CentreOne Recent Development
• 11.12 Delpharm
  • 11.12.1 Delpharm Company Details
  • 11.12.2 Delpharm Business Overview
  • 11.12.3 Delpharm Full-Service CDMO Introduction
  • 11.12.4 Delpharm Revenue in Full-Service CDMO Business (2019-2024)
  • 11.12.5 Delpharm Recent Development
• 11.13 Recipharm
  • 11.13.1 Recipharm Company Details
  • 11.13.2 Recipharm Business Overview
  • 11.13.3 Recipharm Full-Service CDMO Introduction
  • 11.13.4 Recipharm Revenue in Full-Service CDMO Business (2019-2024)
  • 11.13.5 Recipharm Recent Development
• 11.14 AGC Pharma Chemicals
  • 11.14.1 AGC Pharma Chemicals Company Details
  • 11.14.2 AGC Pharma Chemicals Business Overview
  • 11.14.3 AGC Pharma Chemicals Full-Service CDMO Introduction
  • 11.14.4 AGC Pharma Chemicals Revenue in Full-Service CDMO Business (2019-2024)
  • 11.14.5 AGC Pharma Chemicals Recent Development
• 11.15 Boehringer Ingelheim
  • 11.15.1 Boehringer Ingelheim Company Details
  • 11.15.2 Boehringer Ingelheim Business Overview
  • 11.15.3 Boehringer Ingelheim Full-Service CDMO Introduction
  • 11.15.4 Boehringer Ingelheim Revenue in Full-Service CDMO Business (2019-2024)
  • 11.15.5 Boehringer Ingelheim Recent Development
• 11.16 Vetter
  • 11.16.1 Vetter Company Details
  • 11.16.2 Vetter Business Overview
  • 11.16.3 Vetter Full-Service CDMO Introduction
  • 11.16.4 Vetter Revenue in Full-Service CDMO Business (2019-2024)
  • 11.16.5 Vetter Recent Development
• 11.17 Curia
  • 11.17.1 Curia Company Details
  • 11.17.2 Curia Business Overview
  • 11.17.3 Curia Full-Service CDMO Introduction
  • 11.17.4 Curia Revenue in Full-Service CDMO Business (2019-2024)
  • 11.17.5 Curia Recent Development
• 11.18 Aenova
  • 11.18.1 Aenova Company Details
  • 11.18.2 Aenova Business Overview
  • 11.18.3 Aenova Full-Service CDMO Introduction
  • 11.18.4 Aenova Revenue in Full-Service CDMO Business (2019-2024)
  • 11.18.5 Aenova Recent Development
• 11.19 Porton
  • 11.19.1 Porton Company Details
  • 11.19.2 Porton Business Overview
  • 11.19.3 Porton Full-Service CDMO Introduction
  • 11.19.4 Porton Revenue in Full-Service CDMO Business (2019-2024)
  • 11.19.5 Porton Recent Development
• 11.20 Piramal
  • 11.20.1 Piramal Company Details
  • 11.20.2 Piramal Business Overview
  • 11.20.3 Piramal Full-Service CDMO Introduction
  • 11.20.4 Piramal Revenue in Full-Service CDMO Business (2019-2024)
  • 11.20.5 Piramal Recent Development
• 11.21 Strides Pharma
  • 11.21.1 Strides Pharma Company Details
  • 11.21.2 Strides Pharma Business Overview
  • 11.21.3 Strides Pharma Full-Service CDMO Introduction
  • 11.21.4 Strides Pharma Revenue in Full-Service CDMO Business (2019-2024)
  • 11.21.5 Strides Pharma Recent Development
• 11.22 NextPharma
  • 11.22.1 NextPharma Company Details
  • 11.22.2 NextPharma Business Overview
  • 11.22.3 NextPharma Full-Service CDMO Introduction
  • 11.22.4 NextPharma Revenue in Full-Service CDMO Business (2019-2024)
  • 11.22.5 NextPharma Recent Development
• 11.23 Famar
  • 11.23.1 Famar Company Details
  • 11.23.2 Famar Business Overview
  • 11.23.3 Famar Full-Service CDMO Introduction
  • 11.23.4 Famar Revenue in Full-Service CDMO Business (2019-2024)
  • 11.23.5 Famar Recent Development
• 11.24 Jubilant
  • 11.24.1 Jubilant Company Details
  • 11.24.2 Jubilant Business Overview
  • 11.24.3 Jubilant Full-Service CDMO Introduction
  • 11.24.4 Jubilant Revenue in Full-Service CDMO Business (2019-2024)
  • 11.24.5 Jubilant Recent Development
• 11.25 Alcami
  • 11.25.1 Alcami Company Details
  • 11.25.2 Alcami Business Overview
  • 11.25.3 Alcami Full-Service CDMO Introduction
  • 11.25.4 Alcami Revenue in Full-Service CDMO Business (2019-2024)
  • 11.25.5 Alcami Recent Development
• 11.26 Euroapi
  • 11.26.1 Euroapi Company Details
  • 11.26.2 Euroapi Business Overview
  • 11.26.3 Euroapi Full-Service CDMO Introduction
  • 11.26.4 Euroapi Revenue in Full-Service CDMO Business (2019-2024)
  • 11.26.5 Euroapi Recent Development
• 11.27 Eurofins
  • 11.27.1 Eurofins Company Details
  • 11.27.2 Eurofins Business Overview
  • 11.27.3 Eurofins Full-Service CDMO Introduction
  • 11.27.4 Eurofins Revenue in Full-Service CDMO Business (2019-2024)
  • 11.27.5 Eurofins Recent Development
• 11.28 Avid Bioservices
  • 11.28.1 Avid Bioservices Company Details
  • 11.28.2 Avid Bioservices Business Overview
  • 11.28.3 Avid Bioservices Full-Service CDMO Introduction
  • 11.28.4 Avid Bioservices Revenue in Full-Service CDMO Business (2019-2024)
  • 11.28.5 Avid Bioservices Recent Development
• 11.29 BioVectra
  • 11.29.1 BioVectra Company Details
  • 11.29.2 BioVectra Business Overview
  • 11.29.3 BioVectra Full-Service CDMO Introduction
  • 11.29.4 BioVectra Revenue in Full-Service CDMO Business (2019-2024)
  • 11.29.5 BioVectra Recent Development
• 11.30 CPL
  • 11.30.1 CPL Company Details
  • 11.30.2 CPL Business Overview
  • 11.30.3 CPL Full-Service CDMO Introduction
  • 11.30.4 CPL Revenue in Full-Service CDMO Business (2019-2024)
  • 11.30.5 CPL Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer